InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: the gipper post# 121211

Tuesday, 01/12/2016 8:29:40 AM

Tuesday, January 12, 2016 8:29:40 AM

Post# of 130502
gipper: I appreciate your feedback and posts as well. You would think at some point a CEO should set a reasonable timeframe to measure one's personal performance (and if he or she is capable of growing a bona fide business as this business is extremely complex ...and he really doesnt have the proper credentials but has very talented people surrounding him).

The biotech business (and as a startup here) is hard to handicap as they are bringing assets along and having them mature like a fine wine (hence...without the proper funding). Each day going forward...could see a monumental announcement that triples or quadruples the stock price.

They have to monetize somewhere in the pipeline:

a) Gene therapy - partnerships via Wallachbeth investment firm
b) eltoprazine - partnership via a pharma. or investment firm
c) DX Transaction - spin out
d) Venture capital - its the latter here which intrigues me as to why there hasnt been any investments from these types of firms. Or MJFF.
e) Govt funding - DOJ....grants.
f) Govt vouchers - the holy grail...in my opinion. for Rare diseases.

So many opportunities to find $$$...hard to figure why its always taking so long.

Note to Gerald ..you work for the shareholders (not your personal agenda).